Skip to ContentSkip to Navigation
About us Latest news News News articles

Improving the response to molecular targeting of the TRAIL death receptors in colon cancer cells

28 June 2010

PhD ceremony: Mr. B.E. Pennarun, 13.15 uur, Academiegebouw, Broerstraat 5, Groningen

Thesis: Improving the response to molecular targeting of the TRAIL death receptors in colon cancer cells

Promotor(s): prof. J.H. Kleibeuker, prof. E.G.E. de Vries

Faculty: Medical Sciences

 

It is important to develop new therapeutic options that will contribute to the improvement of colorectal cancer treatment. Chemotherapy can induce programmed cell death (apoptosis) in cancer cells. The apoptotic pathway, which is mediated by the mitochondria, is often disrupted in therapy-resistant cancer cells. An alternate route can be used to induce apoptosis in cancer cells, by using tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to activate the so-called “death receptors “at the cell membrane. In this thesis, we investigate which chemotherapeutic agents can increase the response to TRAIL in cancer cells, and the role played by the death receptors TRAIL-R1 and TRAIL-R2 in these effects.

 

Last modified:13 March 2020 01.15 a.m.
View this page in: Nederlands

More news

  • 27 August 2024

    UMCG gaat onderzoeksfaciliteiten beschikbaar stellen voor geneesmiddelenontwikkeling

    Om de beschikbaarheid en effectiviteit van geneesmiddelen in Nederland te verbeteren gaat het UMCG het bedrijf G² Solutions opzetten. Dit bedrijf moet ervoor gaan zorgen dat belangrijke technologische ontwikkelingen op het gebied van DNA sequencing...

  • 17 July 2024

    Veni-grants for ten researchers

    The Dutch Research Council (NWO) has awarded a Veni grant of up to €320,000 each to ten researchers of the University of Groningen and the UMCG. The Veni grants are designed for outstanding researchers who have recently gained a PhD.

  • 16 July 2024

    Medicine still subjects to male bias

    Aranka Ballering studied the course of illness in people with common symptoms. One of the most striking findings to emerge from her research was that on average, women have a different – and less extensive – course of illness than men.